ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STTK vs IRWD // FORWARD P/E MULTIPLE

Shattuck Labs Inc. (NASDAQ) VS. Ironwood Pharmaceuticals Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: STTK 2 — IRWD 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STTK VS. IRWD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STTK IRWD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 85.00% -120.00 IRWD /roic <GO>
EV/EBITDA & P/E Valuation — 3.9x — TIE /valuation <GO>
Free Cash Flow Yield -6.96% 21.23% -28.19 IRWD /fcf-yield <GO>
Operating Margin -60.00% 33.30% -93.30 IRWD /operating-margins <GO>
Net Profit Margin -60.00% 8.10% -68.10 IRWD /net-margins <GO>
Revenue Growth (YoY) -65.00% -15.70% -49.30 IRWD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 0.20 +25.80 STTK /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 IRWD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.8 41.9 +1.90 STTK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 23.2x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $558.0M $578.3M -$20.3M IRWD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STTK REV IRWD REV STTK GROSS % IRWD GROSS % STTK FCF IRWD FCF
FY 2025 $1.0M $296.2M — — -$40.0M $127.0M
FY 2024 $5.7M $351.4M — — -$60.6M $103.4M
FY 2023 $1.7M $442.7M — — -$81.2M $183.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STTK // BETA —
IRWD // BETA —